Načítá se...

Markedly elevated neonatal immunoreactive trypsinogen levels in the absence of cystic fibrosis gene mutations is not an indication for further testing

AIMS: To investigate the immunoreactive trypsinogen (IRT) values above the usual 99th centile laboratory cut‐off and determine the value of offering further testing to those infants with a markedly elevated IRT but no cystic fibrosis transmembrane regulator (CFTR) gene mutation identified by the scr...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Massie, J, Curnow, L, Tzanakos, N, Francis, I, Robertson, C F
Médium: Artigo
Jazyk:Inglês
Vydáno: BMJ Group 2006
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2065933/
https://ncbi.nlm.nih.gov/pubmed/16243854
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/adc.2005.081349
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!